Dabigatran “non-inferior” to warfarin, but only justBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f1219 (Published 27 February 2013) Cite this as: BMJ 2013;346:f1219
New oral anticoagulants offer the prospect of stability and convenience for people needing treatment for a recent deep vein thrombosis or pulmonary embolus. They might also allow longer term treatment to prevent recurrence, and Boehringer Ingelheim recently reported results from …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial